The use of performance and image-enhancing drugs (PIEDs) is rising in Australia. PIED use is associated with a range of serious health issues, including the transmission of blood-borne viruses, especially hepatitis C (HCV), due to PIED injecting. Little is known about PIED injecting in Australia, and the nation's existing harm reduction framework is unprepared to meet the unique challenges it poses. This qualitative interview-based project will generate new knowledge on PIED use, the meanings associated with it, and the health information needs of PIED injectors. It will directly inform policy and practice, potentially helping to avert an epidemic of HCV in this rapidly emerging, hitherto neglected population of people who inject drugs.
Prof Suzanne Fraser (Curtin University) Prof David Moore (Curtin University) Dr Kate Seear (Monash University)
The aim of this interdisciplinary project is to investigate the legal and ethical implications of technologies that allow inheritable modifications of the human genome. The use of these technologies in human embryos is fast becoming an international reality, and this project aims to be the first to rigorously examine the implications of this in the Australian context. The intended outcomes of the Project are to clarify the current legal status of inheritable genetic modification technologies in Australia, provide a comprehensive analysis of the ethics of these new technologies, and, building on this, propose a set of recommendations for regulatory reform to guide Australia’s response to international scientific and legal developments.
A/Prof Catherine Mills (Faculty of Arts) A/Prof Karinne Ludlow Prof Robert Sparrow (Faculty of Arts) Dr Narelle Warren (Faculty of Arts)
This project will reveal the way in which other legal rules and principles influence the effect that a statutory provision has on the content of the law. This will resolve some central debates in statutory interpretation, and in doing so provide guidance to judges and a better understanding of how statute law works in Australia.